{"id":"NCT00403767","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","briefTitle":"An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation","officialTitle":"A Prospective, Randomized, Double-Blind, Parallel-Group, Multicenter, Non-inferiority Study Comparing the Efficacy and Safety of Rivaroxaban (BAY 59-7939) With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Subjects With Non-Valvular Atrial Fibrillation","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-12","primaryCompletion":"2010-09","completion":"2010-09","firstPosted":"2006-11-27","resultsPosted":"2012-07-17","lastUpdate":"2014-04-29"},"enrollment":14269,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Atrial Fibrillation","Stroke","Embolism"],"interventions":[{"type":"DRUG","name":"Rivaroxaban","otherNames":[]},{"type":"DRUG","name":"Warfarin","otherNames":[]},{"type":"DRUG","name":"Matching placebo for Rivaroxaban arm (Warfarin placebo)","otherNames":[]},{"type":"DRUG","name":"Matching placebo for Warfarin arm (Rivaroxaban placebo)","otherNames":[]}],"arms":[{"label":"Rivaroxaban","type":"EXPERIMENTAL"},{"label":"Warfarin","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to compare the efficacy and safety of rivaroxaban with warfarin for the prevention of blood clots in the brain (referred to as stroke) and blood clots in other parts of the body referred to as non-central nervous system systemic embolism) in patients with non-valvular atrial fibrillation (a heart rhythm disorder).","primaryOutcome":{"measure":"The Composite Event of Stroke/Non-CNS Systemic Embolism: Primary Efficacy (Non-Inferiority)","timeFrame":"Up to 4 years","effectByArm":[{"arm":"Rivaroxaban","deltaMin":188,"sd":null},{"arm":"Warfarin","deltaMin":241,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":6},"locations":{"siteCount":932,"countries":["United States","Argentina","Australia","Austria","Belgium","Brazil","Bulgaria","Canada","Chile","China","Colombia","Czechia","Denmark","Finland","France","Germany","Greece","Hong Kong","Hungary","India","Israel","Lithuania","Malaysia","Mexico","Netherlands","New Zealand","Norway","Peru","Philippines","Poland","Romania","Russia","Singapore","South Africa","South Korea","Spain","Sweden","Switzerland","Taiwan","Thailand","Turkey (TÃ¼rkiye)","Ukraine","United Kingdom","Venezuela"]},"refs":{"pmids":["40163217","31376090","30371223","30219887","29898836","28615214","28477860","28433206","28264892","27358435","26955859","26888572","26673560","26386791","25749644","25736441","24668660","24552831","24315894","23778903","23723250","23525418","23500298","23212720","22402056","21830957","20211293"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2649,"n":7111},"commonTop":["Epistaxis","Dizziness","Oedema Peripheral","Nasopharyngitis","Diarrhoea"]}}